BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 18483365)

  • 41. Expression of regenerating gene I in gastric adenocarcinomas: correlation with tumor differentiation status and patient survival.
    Dhar DK; Udagawa J; Ishihara S; Otani H; Kinoshita Y; Takasawa S; Okamoto H; Kubota H; Fujii T; Tachibana M; Nagasue N
    Cancer; 2004 Mar; 100(6):1130-6. PubMed ID: 15022278
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR.
    Mrena J; Wiksten JP; Thiel A; Kokkola A; Pohjola L; Lundin J; Nordling S; Ristimäki A; Haglund C
    Clin Cancer Res; 2005 Oct; 11(20):7362-8. PubMed ID: 16243808
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression and prognostic significance of prothymosin-alpha and ERp57 in human gastric cancer.
    Leys CM; Nomura S; LaFleur BJ; Ferrone S; Kaminishi M; Montgomery E; Goldenring JR
    Surgery; 2007 Jan; 141(1):41-50. PubMed ID: 17188166
    [TBL] [Abstract][Full Text] [Related]  

  • 44. STAT3 as a prognostic marker in human gastric cancer.
    Jackson CB; Giraud AS
    J Gastroenterol Hepatol; 2009 Apr; 24(4):505-7. PubMed ID: 19368630
    [No Abstract]   [Full Text] [Related]  

  • 45. Inverse association between Bmi-1 and RKIP affecting clinical outcome of gastric cancer and revealing the potential molecular mechanisms underlying tumor metastasis and chemotherapy resistance.
    Chen Y; Lian G; Ou G; Yang K; Chen J; Li H; Chen S; Li J; Zeng L; Huang K
    Gastric Cancer; 2016 Apr; 19(2):392-402. PubMed ID: 25764514
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Neurotrophic receptor, tropomyosin-related kinase B as an independent prognostic marker in gastric cancer patients.
    Tanaka K; Mohri Y; Nishioka J; Kobayashi M; Ohi M; Miki C; Tonouchi H; Nobori T; Kusunoki M
    J Surg Oncol; 2009 Apr; 99(5):307-10. PubMed ID: 19170129
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression levels of cyclin G2, but not cyclin E, correlate with gastric cancer progression.
    Choi MG; Noh JH; An JY; Hong SK; Park SB; Baik YH; Kim KM; Sohn TS; Kim S
    J Surg Res; 2009 Dec; 157(2):168-74. PubMed ID: 19559447
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical significance of nm23 gene expression in gastric cancer.
    Mönig SP; Nolden B; Lübke T; Pohl A; Grass G; Schneider PM; Dienes HP; Hölscher AH; Baldus SE
    Anticancer Res; 2007; 27(4C):3029-33. PubMed ID: 17695492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression and prognostic significance of human growth and transformation-dependent protein in gastric carcinoma and gastric adenoma.
    Cho YE; Kim JY; Kim YW; Park JH; Lee S
    Hum Pathol; 2009 Jul; 40(7):975-81. PubMed ID: 19269009
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Signal transducers and activators of transcription 3 activation is involved in nuclear accumulation of beta-catenin in colorectal cancer.
    Kawada M; Seno H; Uenoyama Y; Sawabu T; Kanda N; Fukui H; Shimahara Y; Chiba T
    Cancer Res; 2006 Mar; 66(6):2913-7. PubMed ID: 16540637
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gene expression of estrogen receptor, progesterone receptor and microtubule-associated protein Tau in high-risk early breast cancer: a quest for molecular predictors of treatment benefit in the context of a Hellenic Cooperative Oncology Group trial.
    Pentheroudakis G; Kalogeras KT; Wirtz RM; Grimani I; Zografos G; Gogas H; Stropp U; Pectasides D; Skarlos D; Hennig G; Samantas E; Bafaloukos D; Papakostas P; Kalofonos HP; Pavlidis N; Fountzilas G
    Breast Cancer Res Treat; 2009 Jul; 116(1):131-43. PubMed ID: 18668363
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association of cortactin and fascin-1 expression in gastric adenocarcinoma: correlation with clinicopathological parameters.
    Tsai WC; Jin JS; Chang WK; Chan DC; Yeh MK; Cherng SC; Lin LF; Sheu LF; Chao YC
    J Histochem Cytochem; 2007 Sep; 55(9):955-62. PubMed ID: 17510372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of KAI1 expression in gastric cancer.
    Tsutsumi S; Shimura T; Morinaga N; Mochiki E; Asao T; Kuwano H
    Hepatogastroenterology; 2005; 52(61):281-4. PubMed ID: 15783050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Expression of the antiapoptosis gene Survivin predicts poor prognosis of stage III gastric adenocarcinoma.
    Song KY; Jung CK; Park WS; Park CH
    Jpn J Clin Oncol; 2009 May; 39(5):290-6. PubMed ID: 19336448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Loss of RUNX3 expression correlates with differentiation, nodal metastasis, and poor prognosis of gastric cancer.
    Hsu PI; Hsieh HL; Lee J; Lin LF; Chen HC; Lu PJ; Hsiao M
    Ann Surg Oncol; 2009 Jun; 16(6):1686-94. PubMed ID: 19290488
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of raf kinase inhibitor protein expression on metastasis and progression of human epithelial ovarian cancer.
    Li HZ; Wang Y; Gao Y; Shao J; Zhao XL; Deng WM; Liu YX; Yang J; Yao Z
    Mol Cancer Res; 2008 Jun; 6(6):917-28. PubMed ID: 18567796
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers.
    Lazăr D; Tăban S; Raica M; Sporea I; Cornianu M; Goldiş A; Vernic C
    Rom J Morphol Embryol; 2008; 49(2):137-48. PubMed ID: 18516318
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Activated STAT3 as a correlate of distant metastasis in prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 86-10.
    Torres-Roca JF; DeSilvio M; Mora LB; Khor LY; Hammond E; Ahmad N; Jove R; Forman J; Lee RJ; Sandler H; Pollack A
    Urology; 2007 Mar; 69(3):505-9. PubMed ID: 17382154
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer.
    Minoo P; Zlobec I; Baker K; Tornillo L; Terracciano L; Jass JR; Lugli A
    Am J Clin Pathol; 2007 May; 127(5):820-7. PubMed ID: 17439843
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.
    Aziz MH; Manoharan HT; Church DR; Dreckschmidt NE; Zhong W; Oberley TD; Wilding G; Verma AK
    Cancer Res; 2007 Sep; 67(18):8828-38. PubMed ID: 17875724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.